Thrombotic disease is one of the world’s leading causes of morbidity and mortality. The FDA has recently suggested that persons suffering from thrombotic disease take between fifty and three hundred twenty-five milligrams of aspirin per day. Yet, with these increased doses come the aforementioned side effects. Thus, a method that allows health care professionals to determine therapeutically effective dosages quickly and accurately before administering the drug is of great benefit to the populous.
This method is only effective if used, obviously. It would be necessary for the test to be made available to health care providers nationwide, and be put into regular use for those diagnosed with or suspected of suffering from thrombotic disease. While the cost of a urine test would probably not be economically prohibitive, it is just one more test and accompanying fee to add onto the list of procedures and tests patients must already undertake.